Triple combination therapies for anti-aging
US-2024316086-A1 · Sep 26, 2024 · US
US9265707B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9265707-B2 |
| Application number | US-201113637959-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 31, 2011 |
| Priority date | Mar 31, 2010 |
| Publication date | Feb 23, 2016 |
| Grant date | Feb 23, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a cosmetic composition for skin care, comprising coumestrol or a bean extract containing coumestrol.
Opening claim text (preview).
The invention claimed is: 1. A method for inducing an anti-inflammatory or anti-bacterial effect in a subject in need thereof, comprising administering to the skin of the subject a pharmaceutical or cosmetic composition containing coumestrol or a bean extract comprising coumestrol in an amount effective to inducing an anti-inflammatory or anti-bacterial effect in the subject. 2. A method for improving atopic dermatitis in a subject in need thereof, comprising administering to the skin of the subject a pharmaceutical or cosmetic composition containing coumestrol or a bean extract comprising coumestrol in an amount effective to improve the subject's atopic dermatitis. 3. A method for improving a skin allergy in a subject in need thereof, comprising administering to the skin of the subject a pharmaceutical or cosmetic composition containing coumestrol or a bean extract comprising coumestrol in an amount effective to improve the subject's skin allergy. 4. The method of claim 1 , wherein coumestrol is administered in a dose of about 0.1-5000 mg/kg/day. 5. The method of claim 4 , wherein coumestrol is administered in a dose of about 50-500 mg/kg/day. 6. The method of claim 1 , wherein the pharmaceutical or cosmetic composition comprises 0.001-30 wt % of coumestrol or the bean extract comprising coumestrol. 7. The method of claim 6 , wherein the pharmaceutical or cosmetic composition comprises 0.1-5 wt % of coumestrol or the bean extract comprising coumestrol. 8. The method of claim 2 , wherein coumestrol is administered in a dose of about 0.1-5000 mg/kg/day. 9. The method of claim 8 , wherein coumestrol is administered in a dose of about 50-500 mg/kg/day. 10. The method of claim 2 , wherein the pharmaceutical or cosmetic composition comprises 0.001-30 wt % of coumestrol or the bean extract comprising coumestrol. 11. The method of claim 10 , wherein the pharmaceutical or cosmetic composition comprises 0.1-5 wt % of coumestrol or the bean extract comprising coumestrol. 12. The method of claim 3 , wherein coumestrol is administered in a dose of about 0.1-5000 mg/kg/day. 13. The method of claim 12 , wherein coumestrol is administered in a dose of about 50-500 mg/kg/day. 14. The method of claim 3 , wherein the pharmaceutical or cosmetic composition comprises 0.001-30 wt % of coumestrol or the bean extract comprising coumestrol. 15. The method of claim 14 , wherein the pharmaceutical or cosmetic composition comprises 0.1-5 wt % of coumestrol or the bean extract comprising coumestrol.
Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title
Antibacterial agents · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Drugs for dermatological disorders · CPC title
Anti-acne agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.